Gamified Weight Loss Program for Obesity
(DASH-Man Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
Men in the United States have an exceptionally high prevalence of overweight and obesity, i.e., 71.3%, and 42% of men are currently attempting weight loss. However, men are dramatically underrepresented in weight loss programs. Attempts to modestly adapt standard weight loss programs have seen only minimal success. Mobile applications (mHealth apps) have attractive features, but have low male enrollment and poor efficacy as conventionally delivered. A gamified mHealth program offers the possibility of engaging men and enhancing efficacy given that (1) video gaming is highly appealing to men; (2) gamification features (e.g., digital rewards for attaining "streaks" and milestones, competition) are known enhance enjoyment and motivation and facilitate desired behaviors; and (3) "neurotraining" video games featuring repetitive action mechanics, adaptive difficulty, and feedback can train inhibitory control, a basic brain capacity to inhibit intrinsically-generated approach responses that is strongly linked to body mass and the consumption of high-calorie foods. This project evaluates long-term engagement and outcomes of a professionally-designed, game-based weight loss program. As such, 228 overweight men will be randomized to: (1) a 12-month mHealth weight loss program that includes digital self-monitoring, simplified and self-selected dietary targets, physical activity and a control (sham) non-game neurotraining, or (2) a fully-gamified version of this same program, comprised of a behavior change program featuring team-based competition, digital reinforcers for attainment of streaks and milestones, and an integrated neurotraining video game. Aims include evaluating the efficacy of the gamified program in terms of weight loss, diet and physical activity at 12 months, as well as evaluating hypothesized mediators (inhibitory control and engagement), (enjoyment and compliance) and moderators (baseline frequency of video game play and implicit preferences for Inhibitory Control Training-targeted foods).
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you have recently started or changed the dosage of a medication that can significantly affect your weight, you may not be eligible to participate.
Is the gamified weight loss program safe for humans?
What makes the Gamified Weight Loss Program for Obesity unique compared to other treatments?
The Gamified Weight Loss Program is unique because it combines cognitive behavior therapy (CBT) principles with a mobile app designed as a game, allowing users to earn points for both in-app activities and real-world physical activities. This approach makes weight loss more engaging and accessible, especially for young adults with maladaptive eating habits, by using a novel scoring system and gamification to encourage behavior change.12356
What data supports the effectiveness of the Gamified Weight Loss Program for Obesity treatment?
Research shows that gamified and digital interventions, like the SIGMA app, which use cognitive behavior therapy (CBT) principles, can help with weight loss by addressing unhealthy eating habits. Additionally, studies indicate that using behavior change techniques and incentives in digital programs can lead to weight loss, suggesting that similar gamified approaches may be effective.12578
Are You a Good Fit for This Trial?
This trial is for overweight or obese men (BMI of 25-50 kg/m²) aged 18-65 who enjoy high-calorie foods and can walk two city blocks without stopping. They must be willing to have their doctor contacted about their physical activity level and rapid weight loss if needed. Men with certain medical conditions, recent significant weight loss, or changes in medications affecting weight are excluded.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a 12-month mHealth weight loss program with digital self-monitoring, dietary targets, and physical activity, with either a sham or active neurotraining component.
Follow-up
Participants are monitored for weight loss, diet, and physical activity outcomes, with assessments at months 0, 1, 6, and 12.
What Are the Treatments Tested in This Trial?
Interventions
- Gamified behavioral weight loss treatment
- mHealth behavioral weight loss treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
Drexel University
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator